The in-depth Hashimoto's resource · part of the Diabetes & Endocrine Specialists network Call 858-622-7200 Request an appointment
HomeTreating Hashimoto's
Pillar 5 · Treatment

Treating Hashimoto's

For most people, treatment means levothyroxine done carefully — or watchful monitoring when the thyroid still works. Here is who is treated, how dosing and monitoring are handled, and an honest accounting of combination T4/T3, desiccated thyroid, and surgery.

Key takeaways

  • Overt hypothyroidism is treated; a euthyroid, antibody-positive thyroid is monitored, not medicated.
  • Levothyroxine alone is the established treatment and works well for most people.
  • Combination T4/T3, desiccated thyroid, and surgery are not first-line — the evidence for each is graded honestly below.

What this means for you

If your thyroid has become underactive, the goal is straightforward: replace the hormone your thyroid can no longer make, and get you feeling like yourself again. For most people that means one daily tablet and a blood test now and then to fine-tune the dose. If you are still feeling unwell even though your numbers look normal, that is worth taking seriously — this page walks through what is established, what is debated, and what a careful next step looks like.

Treatment of Hashimoto's is, first and foremost, treatment of the hypothyroidism it can cause — and where the thyroid is still working, it is careful monitoring rather than medication. The core interventions here are guideline-defined, which means these pages have low latitude: we state the guideline position, then add context. Because care is individualized, none of this is a substitute for a plan made with your own clinician.

Who is treated, and who is monitored

Overt hypothyroidism is treated. Doing so lowers the rates of heart attack, stroke, atrial fibrillation, heart failure, and cardiovascular death, and reduces overall mortality. A person who is antibody-positive but euthyroid is monitored, typically with an annual TSH, because many never progress and some recover.

Subclinical hypothyroidism sits in between and is the genuinely debated zone. A TSH at or above 10 mIU/L is generally treated; a TSH in the 7–9.9 range is often reasonable to treat, especially in younger or symptomatic people; below that, decisions are individualized. In older adults in particular, the evidence for treating mild subclinical hypothyroidism is weak — a large trial found no quality-of-life benefit — so restraint is appropriate.

Levothyroxine, done well

Levothyroxine (T4) replacement

Grade A · Guideline-supported
Bottom line
The established treatment for hypothyroidism; most people do well on it.
Typical dose
~1.4–1.8 mcg/kg/day at full replacement; older or cardiac patients start low and titrate.
Timing
Empty stomach — 60 min before breakfast, or bedtime ≥3 h after dinner. Several regimens work.
Monitoring
Re-check TSH ~6–8 weeks after any change; once stable, every 6–12 months.

Getting the dose right matters in both directions: in a study of more than 160,000 treated patients, roughly a third were under-treated and one in nine over-treated, and over-treatment in particular carried measurable harm to bone and heart. On TSH targets, there is an honest tension worth naming — the physiologic rationale for aiming at a particular point in the normal range is real, yet several trials of specific within-range targets found no change in quality of life, mood, weight, cognition, cardiovascular events, or fractures.

For clinicians Why we don't chase a within-range TSH target

A 40-study meta-analysis links low-normal TSH to reduced bone density and high-normal TSH to worse cardiometabolic markers — a real physiologic gradient. But prospective trials setting specific within-range goals have not shown changes in patient-centered outcomes. We present the rationale and the null result together, and individualize rather than target a number for its own sake.

Does starting early protect the thyroid?

When hypothyroidism is present, treating it promptly does more than relieve symptoms. Normalizing TSH takes the constant drive off the gland — which can shrink a goiter — and it prevents the slow harms of an underactive thyroid on the heart, cholesterol, and energy. In that practical sense, timely replacement protects both you and the gland, and there is no benefit to waiting once treatment is indicated.

The harder question is what to do before the thyroid has clearly failed — the young patient whose TSH is drifting toward the top of the range while her antibody levels are very high. Here we do not simply wait.

How we practice this

In our practice, a young patient with a high-normal or borderline TSH and a high thyroid-antibody titre — the 22-year-old with a TSH of 4.5 and TPO antibodies in the thousands — is someone we treat early, not someone we watch drift. The combination of youth, a rising TSH, and a heavy antibody load marks a high risk of progression, and a carefully monitored trial of levothyroxine has a low downside: it eases symptoms, takes the strain off the gland, and is easily stopped if it isn't helping. That is even more true for anyone who is symptomatic or planning a pregnancy.

This is a clinical judgment, applied to the high-risk profile — not to every person who happens to carry thyroid antibodies with entirely normal thyroid function. Where the numbers are genuinely reassuring, we monitor. We will always tell you which of those two situations you are in, and why.

Early levothyroxine in high-risk, near-euthyroid Hashimoto's

Grade B · Moderate
Supporting evidence
A high-normal TSH combined with a high antibody titre predicts progression to overt hypothyroidism, and small controlled studies show levothyroxine can lower antibody levels and thyroid volume in this setting.
The caveat
There is no large, long-term trial proving that early treatment changes outcomes decades later, and guidelines stop short of recommending it for every antibody-positive patient.
Where guidelines already agree
For a mildly elevated TSH with symptoms, in a young patient, or before pregnancy, a trial of levothyroxine is within accepted practice.
Our position
We treat the high-risk profile early and monitor the low-risk one — and we say which is which.

Combination T4/T3, NDT, and surgery

The persistently symptomatic patient with a normal TSH is a real clinical problem, and it drives interest in alternatives to levothyroxine alone. Here the evidence has to be stated plainly.

Combination T4/T3 therapy

Grade C · Conflicting
Evidence
The large majority of randomized trials show no benefit over levothyroxine alone.
Guideline
ATA concludes there is insufficient evidence to recommend it routinely.
Open question
A possible responder subgroup carrying a DIO2 gene variant is hypothesized but not confirmed.

Desiccated (porcine) thyroid

Grade D · Experimental
Evidence
Not recommended by the guidelines; its fixed ~4:1 T4:T3 ratio delivers supraphysiologic T3.
Our position
Not a first-line option; considered only case-by-case with a defined endpoint and monitoring.

Thyroidectomy for symptoms (high-antibody, euthyroid)

Grade D · Emerging
Evidence
Rests on a single positive randomized trial — emerging, single-study evidence against a conservative surgical standard.
Our position
Surgery remains reserved for compression or malignancy; we label this what it is.

What we know

  • Treating overt hypothyroidism lowers cardiovascular events and mortality.
  • Levothyroxine alone is correct for most patients.
  • Both under- and over-replacement carry real risk.

What we don't know

  • Whether any within-range TSH target changes patient-centered outcomes.
  • Who, if anyone, truly benefits from adding T3.
  • Whether lowering antibodies (by any means) improves how patients feel.

For the persistently symptomatic minority, a carefully monitored trial of an alternative can be a legitimate option — with conservative dosing, a defined endpoint agreed in advance, and scheduled reassessment. For most people, levothyroxine alone remains correct.

When to call your doctor

  • New palpitations, tremor, or unexplained weight loss on thyroid medication (possible over-replacement).
  • Return of fatigue, weight gain, or cold intolerance after a stable period (possible under-replacement).
  • Pregnancy or planning pregnancy — your dose needs review early, not later.

Questions to ask your doctor

  • Do my thyroid numbers call for treatment now, or for monitoring?
  • What TSH range are we aiming for in my case, and why?
  • When will we recheck my levels after starting or changing a dose?
  • If I still feel unwell with a normal TSH, what would you look into next?
  • Is there any reason to consider anything beyond levothyroxine for me?
How we grade evidence. Every intervention on this site carries a plain label — from established, guideline-supported care through moderate and conflicting evidence to experimental and insufficient. Mechanistic plausibility is not clinical proof: a laboratory or animal mechanism, or a change in an antibody level, is not the same as a demonstrated improvement in how a patient does.

Stress, movement, and everyday wellbeing

Replacing thyroid hormone is the core of treatment, but it isn’t the whole of care. Two things matter enough to name directly. First, stress genuinely aggravates autoimmune disease — not as a vague wellness slogan, but as something we see across autoimmune conditions: sustained stress can worsen symptoms and, for many people, coincides with flares. We can’t prove that lowering your stress reverses Hashimoto’s, and we won’t pretend it does. But managing stress isn’t optional self-care around the edges — it changes how you feel and how well you tolerate the disease, and it’s a legitimate part of the plan.

Second, movement helps. Regular exercise — whatever kind you’ll actually keep doing — improves energy, mood, sleep, weight, and cardiometabolic health, all of which sit right on top of the symptoms people attribute to their thyroid. You don’t need to fear intense exercise with Hashimoto’s; if you’re significantly under-replaced or exhausted, we pace it sensibly while we optimize your treatment, and then we get you moving.

None of this replaces levothyroxine, and none of it is a cure. What it does is treat the whole person: sleep you can count on, stress you can manage, activity you enjoy, and the ordinary foundations of health. In our experience, patients who are well-replaced and supported in these ways feel meaningfully better than those who are only well-replaced — and that is the outcome we are actually after.

Questions patients ask

Real questions we hear about thyroid-hormone treatment — answered the way we would answer them in clinic.

Why was I prescribed levothyroxine instead of Armour Thyroid — isn’t desiccated more natural? Grade A
Levothyroxine is first-line because it’s the most predictable way to replace what’s missing. "Natural" desiccated thyroid works, but it hasn’t beaten levothyroxine in quality trials and delivers a fixed, non-human T4:T3 ratio.

Why patients ask this

"Natural," from an actual gland, prescribed for a century — it sounds preferable, and some people genuinely feel better on it. Both are worth taking seriously.

What the evidence shows

Desiccated thyroid extract (pig-derived) carries a high, fixed amount of T3 that doesn’t match human physiology and produces T3 peaks after dosing; head-to-head trials haven’t shown it’s better for symptoms or outcomes. "Natural" is a marketing frame, not a pharmacologic advantage. The graded evidence is in the combination-therapy and NDT section above.

In our practice

We start with levothyroxine for steady, titratable, single-hormone replacement. If you’re well-replaced by the numbers but still not right, a monitored trial of combination therapy — or occasionally NDT — is on the table for the right person. We just won’t frame "natural" as automatically better.

EvidenceGrade Alevothyroxine first-line ·Grade C · Conflictingdesiccated/combination in selected patients.
Should everyone with Hashimoto’s take T3 in addition to T4? Grade C · Conflicting
No — not everyone. Most randomized trials show no benefit from adding T3 over levothyroxine alone, though a subset of persistently symptomatic people may be worth a monitored trial.

Why patients ask this

If T4-only isn’t fixing how you feel, adding the "active" hormone T3 sounds like the obvious next step, and it’s widely promoted.

What the evidence shows

Across trials the average results don’t favour T4/T3 combination over levothyroxine, and the ATA finds insufficient evidence to recommend it routinely; some patients nonetheless report preferring it. It’s an option for selected, still-symptomatic patients — not a default for everyone.

In our practice

We don’t add T3 reflexively. For the right, well-replaced-but-symptomatic person we’ll trial it with a defined endpoint and monitoring, and stop if it isn’t clearly helping.

EvidenceGrade C · Conflictingcombination T3 in selected patients, not routinely.
Why won’t my doctor increase my dose until my TSH is "optimal"? Grade A
Because the safe, evidence-based target is a TSH in the reference range — and pushing the dose past that to chase an "optimal" number mostly buys risk, not benefit.

Why patients ask this

If a higher dose might mean more energy, it’s frustrating to be held at a number that feels arbitrary while symptoms linger.

What the evidence shows

Replacement is dosed to bring TSH into the normal range; there’s no outcome evidence that suppressing TSH below normal or targeting a particular "optimal" sub-range makes people feel better, and over-replacement carries real harm — atrial fibrillation and accelerated bone loss, especially with age. The "optimal range" targets promoted online aren’t backed by trials.

In our practice

We dose you into the right part of the range and adjust for how you’re doing — not to a number off a chart. If you’re at goal and still symptomatic, we look wider rather than push the dose into a zone that risks your heart and bones.

EvidenceGrade Adose to a normal TSH; over-replacement carries real harm.
My labs are normal but I still feel terrible — should my medication be changed? Grade A
Maybe — but the first step isn’t a dose change, it’s confirming "normal" is truly optimal for you and ruling out non-thyroid causes. Sometimes it’s a medication change; often it’s something else.

Why patients ask this

Feeling unwell while being told your labs are "fine" is one of the most frustrating parts of this disease.

What the evidence shows

Make sure replacement is optimized and taken correctly (empty stomach, consistent timing) first. For persistent symptoms despite good numbers, combination therapy is an option — mixed trials, permitted in selected patients (see the section above). And hypothyroid-type symptoms often have non-thyroid drivers — iron, B12, vitamin D, sleep, mood, perimenopause — worth looking for rather than assuming away.

In our practice

We optimize first, rule the common non-thyroid causes in or out, and — for the right, well-replaced person — discuss a monitored combination trial with a defined endpoint. What we won’t do is dismiss you because a number sits inside a range.

EvidenceGrade Aoptimize first ·Grade C · Conflictingcombination trial in selected patients.
Can thyroid hormone treat my symptoms even if my thyroid tests are normal? Grade E · Insufficient
No. Giving thyroid hormone to someone with normal thyroid tests for nonspecific symptoms isn’t supported and carries real risk.

Why patients ask this

Fatigue, weight, and brain fog are miserable and often thyroid-adjacent, so it’s tempting to try thyroid hormone as a fix even when tests are normal.

What the evidence shows

In people with genuinely normal thyroid function, thyroid hormone hasn’t been shown to improve fatigue, weight, or mood, and using it to push levels around exposes you to the harms of over-replacement — heart rhythm and bone — without a thyroid problem to treat. Symptoms deserve a cause, not a hormone aimed at a gland that’s working.

In our practice

If your thyroid is truly normal, we don’t treat it — we look for what’s actually driving your symptoms. Thyroid hormone is replacement for a failing gland, not a tonic for tiredness.

EvidenceGrade E · Insufficientthyroid hormone for symptoms with normal thyroid tests.

Ready for thyroid care that takes your questions seriously?

Board-certified endocrinologists. Physician-scientists. Straight answers about what works and what does not.

Call Request Appointment
One San Diego endocrine group, specialized centers: Diabetes & Endocrine Specialists · SanDiEndo — Interventional Endocrinology · MenoExperts — Menopause & Midlife · HashiExperts — Hashimoto's Care · EndoTrials — Clinical Research